News: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

8,306JPY
17 Apr 2015
Change (% chg)

¥-6 (-0.07%)
Prev Close
¥8,312
Open
¥8,270
Day's High
¥8,341
Day's Low
¥8,257
Volume
1,107,400
Avg. Vol
2,933,389
52-wk High
¥9,756
52-wk Low
¥3,878

Search Stocks
Select another date:

Thu, Apr 9 2015

Photo

Japan's Eisai to cut about 450 jobs in U.S.

- Japanese pharmaceutical company Eisai Co Ltd said it would cut about 25 percent, or about 450 jobs, in the United States as part of a realignment to create a more efficient and focused company.

Japan's Eisai to cut about 450 jobs in U.S.

April 9 - Japanese pharmaceutical company Eisai Co Ltd said it would cut about 25 percent, or about 450 jobs, in the United States as part of a realignment to create a more efficient and focused company.

Nikkei edges down after US shares fall; cum-dividend buying limits losses

* Eisai drops on after soaring 32 pct over the last 2 days * Positive themes about Japan market may continue - analyst By Ayai Tomisawa TOKYO, March 25 - Japan's Nikkei share average edged down on Wednesday morning in choppy trade as U.S. shares languished, but losses were limited by investor appetite for stocks before they go ex-dividend later this week. The Nikkei benchmark fell 0.2 percent to 19,677.45 in mid-morning trade after trading in positive territory earlier

Nikkei rises to fresh 15-year high; Eisai soars on hopes for Alzheimer's drug

TOKYO, March 23 - Japan's Nikkei share average rose to a fresh 15-year high on Monday, tracking gains in U.S. shares, while Eisai Co jumped 21 percent after a brokerage upgraded the stock, citing the effectiveness of its drug to treat Alzheimer's disease. The Nikkei ended 1.0 percent higher at 19,754.36 points, its highest closing level since April 2000. The broader Topix gained 0.7 percent to 1,592.25. But trading was thin, with only 1.86 billion shares changing hands, the low

Nikkei rises to fresh 15-year high; drugmaker Eisai soars after upgrade

* Eisai jumps 20 pct on Barclays' rating hike citing Alzheimer's drug hope * Sharp soars after Hon Hai says it is considering rescuing * Nikkei's 20,000 in sight near term - analysts By Ayai Tomisawa TOKYO, March 23 - Japan's Nikkei share average rose to a fresh 15-year high on Monday, tracking gains in U.S. shares, while Eisai Co jumped over 20 percent after a brokerage upgraded the stock, citing the effectiveness of its drug to treat Alzheimer's disease. Eisai so

FDA approves Eisai's thyroid cancer drug

- The U.S. Food and Drug Administration said it approved Japan's Eisai Co Ltd's drug to treat the most common form of thyroid cancer more than two months ahead of the review date.

REFILE-UPDATE 1-FDA approves Eisai's thyroid cancer drug

Feb 13 - The U.S. Food and Drug Administration said it approved Japan's Eisai Co Ltd's drug to treat the most common form of thyroid cancer more than two months ahead of the review date.

BRIEF-Oncodesign enters into services agreement with Eisai

* Says it has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier line metastatic breast cancer treatment

Select another date:
Search Stocks